Free Trial
→ Claim Your FREE Protection Guide (From American Alternative) (Ad) Buy ARDX Stock  Free ARDX Stock Alerts

Ardelyx (ARDX) Financials

Ardelyx logo
$4.82 +0.22 (+4.78%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$4.86 +0.04 (+0.83%)
As of 04/17/2025 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Ardelyx

Annual Income Statements for Ardelyx

This table shows Ardelyx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -3.21 18 -112 -64 -91 -95 -94 -158 -67 -66 -39
Consolidated Net Income / (Loss)		 -3.21 -30 -112 -64 -91 -95 -94 -158 -67 -66 -39
Net Income / (Loss) Continuing Operations		 -3.21 18 -112 -64 -91 -95 -94 -158 -67 -66 -39
Total Pre-Tax Income 		-3.15 -30 -112 -63 -91 -95 -94 -158 -67 -66 -39
Total Operating Income		 -1.56 -29 -113 -65 -91 -91 -91 -154 -64 -63 -28
Total Gross Profit		 32 24 0.00 34 2.14 4.68 7.43 9.10 48 107 283
Total Revenue		 32 24 0.00 42 2.61 5.28 7.57 10 52 124 334
Operating Revenue		 32 24 0.00 42 2.61 5.28 7.57 10 52 124 334
Total Cost of Revenue		 0.00 0.00 0.00 8.40 0.47 0.60 0.15 1.00 4.12 18 51
Operating Cost of Revenue		 - 0.00 0.00 8.40 0.47 0.60 0.15 1.00 4.12 18 51
Total Operating Expenses		 33 5.36 113 99 93 96 98 163 112 170 311
Selling, General & Admin Expense		 7.29 14 19 23 24 24 33 72 77 134 259
Research & Development Expense		 26 40 94 75 69 72 65 91 35 36 52
Total Other Income / (Expense), net		 -1.58 -0.26 0.51 1.96 -0.35 -3.37 -3.53 -3.82 -3.44 -2.24 -11
Interest Expense		 - - 0.00 - 3.53 5.73 5.10 4.50 5.07 8.87 20
Other Income / (Expense), net		 -1.58 -0.26 0.51 1.96 3.19 2.35 1.57 0.69 1.63 6.63 9.17
Income Tax Expense		 0.07 -0.03 0.00 1.18 0.00 0.30 0.00 0.00 0.01 0.55 0.27
Basic Earnings per Share		 ($0.31) ($1.29) ($2.80) ($1.36) ($1.62) ($1.47) ($1.05) ($1.52) ($0.42) ($0.30) ($0.17)
Weighted Average Basic Shares Outstanding		 10.25M 22.89M 40.12M 47.44M 56.22M 64.48M 89.58M 104.21M 158.69M 219.33M 235.23M
Diluted Earnings per Share		 ($0.31) ($1.29) ($2.80) ($1.36) ($1.62) ($1.47) ($1.05) ($1.52) ($0.42) ($0.30) ($0.17)
Weighted Average Diluted Shares Outstanding		 10.25M 22.89M 40.12M 47.44M 56.22M 64.48M 89.58M 104.21M 158.69M 219.33M 235.23M
Weighted Average Basic & Diluted Shares Outstanding		 10.25M 22.89M 40.12M 47.44M 56.22M 64.48M 89.58M 130.29M 206.49M 232.69M 238.36M

Quarterly Income Statements for Ardelyx

This table shows Ardelyx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders		 -23 11 -27 -17 6.63 -29 -27 -16 -0.81 4.65
Consolidated Net Income / (Loss)		 -23 11 -27 -17 6.63 -29 -27 -16 -0.81 4.65
Net Income / (Loss) Continuing Operations		 -23 11 -27 -17 6.63 -29 -27 -16 -0.81 4.65
Total Pre-Tax Income 		-23 11 -27 -17 6.83 -28 -26 -16 -0.77 4.68
Total Operating Income		 -22 12 -26 -17 7.40 -28 -25 -14 2.23 8.13
Total Gross Profit		 4.25 41 9.83 19 49 29 39 64 83 98
Total Revenue		 4.99 44 11 22 56 34 46 73 98 116
Operating Revenue		 4.99 44 11 22 56 34 46 73 98 116
Total Cost of Revenue		 0.73 3.16 1.54 3.49 7.69 5.08 7.13 9.44 16 18
Operating Cost of Revenue		 0.73 3.16 1.54 3.49 7.69 5.08 7.13 9.44 16 18
Total Operating Expenses		 26 29 36 35 41 57 64 77 80 90
Selling, General & Admin Expense		 19 20 27 27 33 48 53 65 65 76
Research & Development Expense		 7.47 9.14 9.09 8.28 8.64 9.52 11 13 15 14
Total Other Income / (Expense), net		 -1.01 -1.46 -0.70 -0.50 -0.57 -0.48 -1.72 -2.76 -3.00 -3.45
Interest Expense		 1.72 1.83 2.00 2.04 2.03 2.81 4.06 4.90 5.28 5.85
Other Income / (Expense), net		 0.70 0.38 1.30 1.55 1.46 2.32 2.34 2.15 2.28 2.41
Income Tax Expense		 0.00 - 0.01 0.00 0.20 0.33 0.12 0.07 0.04 0.04
Basic Earnings per Share		 ($0.14) $0.12 ($0.13) ($0.08) $0.03 ($0.12) ($0.11) ($0.07) $0.00 $0.01
Weighted Average Basic Shares Outstanding		 165.10M 158.69M 207.02M 214.95M 222.78M 219.33M 233.07M 234.57M 235.91M 235.23M
Diluted Earnings per Share		 ($0.14) $0.12 ($0.13) ($0.08) $0.03 ($0.12) ($0.11) ($0.07) $0.00 $0.01
Weighted Average Diluted Shares Outstanding		 165.10M 158.69M 207.02M 214.95M 227.89M 219.33M 233.07M 234.57M 235.91M 235.23M
Weighted Average Basic & Diluted Shares Outstanding		 187.46M 206.49M 214.46M 217.86M 232.14M 232.69M 233.98M 235.43M 236.85M 238.36M

Annual Cash Flow Statements for Ardelyx

This table details how cash moves in and out of Ardelyx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 73 -0.28 -32 0.79 3.39 102 -90 -19 24 -75 43
Net Cash From Operating Activities		 13 -72 -93 -65 -70 -76 -81 -153 -70 -90 -45
Net Cash From Continuing Operating Activities		 13 -72 -93 -65 -70 -76 -81 -153 -70 -90 -45
Net Income / (Loss) Continuing Operations		 -3.21 -30 -112 -64 -91 -95 -94 -158 -67 -66 -39
Consolidated Net Income / (Loss)		 -3.21 -30 -112 -64 -91 -95 -94 -158 -67 -66 -39
Depreciation Expense		 0.30 0.83 1.30 2.64 2.68 2.50 2.54 2.81 1.14 1.29 2.06
Amortization Expense		 0.00 0.46 0.45 0.58 -0.65 0.76 0.41 0.28 1.96 4.22 7.40
Non-Cash Adjustments To Reconcile Net Income		 3.29 2.70 5.32 9.59 9.53 16 13 5.04 8.79 7.56 45
Changes in Operating Assets and Liabilities, net		 13 -46 13 -14 9.46 -0.83 -3.56 -2.52 -15 -37 -61
Net Cash From Investing Activities		 -1.86 -3.45 -131 65 -30 23 -31 51 18 -131 -18
Net Cash From Continuing Investing Activities		 -1.86 -3.45 -131 65 -30 23 -31 51 18 -131 -18
Purchase of Property, Plant & Equipment		 -1.86 -3.45 -4.87 -2.36 -0.31 -0.33 -0.32 -1.87 -0.06 -0.34 -1.01
Purchase of Investments		 0.00 0.00 -134 -84 -169 -103 -151 -73 -50 -215 -195
Sale of Property, Plant & Equipment		 - - - - - - 0.00 0.00 1.80 0.00 0.00
Sale and/or Maturity of Investments		 0.00 0.00 7.60 152 139 126 120 126 67 84 178
Net Cash From Financing Activities		 61 75 191 0.69 104 155 23 83 75 146 107
Net Cash From Continuing Financing Activities		 61 75 191 0.69 104 155 23 83 75 146 107
Repayment of Debt		 -0.00 - - - 0.00 0.00 -0.13 -19 -33 0.00 0.00
Issuance of Debt		 - 0.03 0.00 - 49 - 0.00 0.00 27 22 99
Issuance of Common Equity		 61 75 191 0.62 0.49 21 23 103 72 120 8.14
Other Financing Activities, net		 - - - 0.06 54 135 0.00 -0.11 9.58 3.50 -1.00
Cash Interest Paid		 - - - - 3.07 4.92 4.20 3.47 2.90 4.24 11
Cash Income Taxes Paid		 0.00 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.05 0.27

Quarterly Cash Flow Statements for Ardelyx

This table details how cash moves in and out of Ardelyx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents		 8.22 35 -3.65 -62 3.71 -12 15 5.74 5.54 18
Net Cash From Operating Activities		 -25 14 -45 -15 -21 -8.72 -36 -19 0.50 9.81
Net Cash From Continuing Operating Activities		 -25 14 -45 -15 -21 -8.72 -36 -19 0.50 9.81
Net Income / (Loss) Continuing Operations		 -23 11 -27 -17 6.63 -29 -27 -16 -0.81 4.65
Consolidated Net Income / (Loss)		 -23 11 -27 -17 6.63 -29 -27 -16 -0.81 4.65
Depreciation Expense		 0.28 0.13 -0.00 0.64 0.29 0.36 0.44 0.57 0.54 0.52
Amortization Expense		 0.90 0.91 1.04 2.87 -0.82 1.13 1.75 1.66 2.01 1.98
Non-Cash Adjustments To Reconcile Net Income		 4.00 9.03 4.05 2.07 6.18 -4.73 21 7.03 0.98 17
Changes in Operating Assets and Liabilities, net		 -7.72 -6.47 -23 -3.59 -33 23 -32 -12 -2.22 -14
Net Cash From Investing Activities		 -0.83 1.44 -9.78 -59 -33 -30 -2.57 24 2.34 -42
Net Cash From Continuing Investing Activities		 -0.83 1.44 -9.78 -59 -33 -30 -2.57 24 2.34 -42
Purchase of Property, Plant & Equipment		 - -0.06 -0.01 -0.09 -0.19 -0.04 -0.15 -0.13 -0.14 -0.59
Purchase of Investments		 -18 -6.50 -21 -67 -50 -78 -34 -23 -40 -99
Sale and/or Maturity of Investments		 17 8.00 11 8.25 17 48 32 47 42 58
Net Cash From Financing Activities		 34 19 51 12 58 26 53 1.61 2.70 49
Net Cash From Continuing Financing Activities		 34 19 51 12 58 26 53 1.61 2.70 49
Issuance of Debt		 - - 0.00 - - 22 50 - - 50
Issuance of Common Equity		 34 19 51 12 58 0.10 3.22 1.61 2.70 0.61
Cash Interest Paid		 0.72 0.82 0.86 0.90 0.94 1.55 2.10 1.94 2.93 4.45
Cash Income Taxes Paid		 - - 0.00 0.02 - 0.03 0.00 0.27 - -0.01

Annual Balance Sheets for Ardelyx

This table presents Ardelyx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets		 113 117 213 158 183 260 202 150 190 298 436
Total Current Assets		 111 112 204 150 176 252 195 134 154 246 356
Cash & Equivalents		 107 107 75 75 79 181 91 72 96 21 65
Short-Term Investments		 - 0.00 126 59 89 66 95 44 28 163 185
Accounts Receivable		 2.58 - 0.00 11 0.09 - 0.00 0.50 7.73 22 58
Inventories, net		 - - - - - - - 0.00 3.28 12 21
Prepaid Expenses		 1.21 5.03 3.17 4.94 3.20 3.80 8.20 16 19 27 27
Plant, Property, & Equipment, net		 2.13 4.71 8.99 8.03 5.61 3.44 1.94 2.36 1.22 1.01 1.50
Total Noncurrent Assets		 0.20 0.20 0.15 0.16 1.35 4.28 4.94 14 35 50 78
Other Noncurrent Operating Assets		 0.10 0.10 0.15 0.16 1.35 4.28 2.83 14 35 50 78
Total Liabilities & Shareholders' Equity		 113 117 213 158 183 260 202 150 190 298 436
Total Liabilities		 53 8.05 20 19 68 73 75 67 92 131 262
Total Current Liabilities		 22 7.72 19 18 18 22 28 53 66 50 78
Accounts Payable		 3.13 2.78 5.64 3.93 1.15 2.19 5.63 4.28 11 11 16
Accrued Expenses		 0.78 2.58 10 11 13 7.25 6.66 7.37 12 15 35
Current Deferred Revenue		 16 - - - - 4.54 4.18 0.00 4.21 7.18 11
Current Employee Benefit Liabilities		 1.65 2.37 3.16 3.23 2.72 4.45 5.67 5.42 7.55 13 15
Other Current Liabilities		 - - - 0.00 1.00 2.61 2.12 3.49 3.89 4.44 1.56
Total Noncurrent Liabilities		 31 0.32 0.78 0.72 50 51 47 14 26 80 185
Long-Term Debt		 - - - 0.00 50 49 47 - 0.00 50 151
Noncurrent Deferred Revenue		 31 - - - - - 0.00 4.73 9.03 8.64 7.23
Other Noncurrent Operating Liabilities		 0.12 0.32 0.78 0.72 - 2.08 0.41 9.75 17 22 27
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 61 109 193 139 116 187 126 83 98 167 173
Total Preferred & Common Equity		 61 109 193 139 116 187 126 83 98 167 173
Total Common Equity		 61 109 193 139 116 187 126 83 98 167 173
Common Stock		 133 210 407 418 481 647 681 796 879 1,013 1,059
Retained Earnings		 -72 -101 -214 -278 -366 -460 -555 -713 -780 -846 -885
Accumulated Other Comprehensive Income / (Loss)		 - 0.00 -0.07 -0.05 -0.04 0.02 -0.00 -0.01 -0.05 0.22 0.06

Quarterly Balance Sheets for Ardelyx

This table presents Ardelyx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets		 145 217 211 289 342 343 368
Total Current Assets		 120 167 162 241 258 263 284
Cash & Equivalents		 62 92 30 34 36 42 47
Short-Term Investments		 29 38 98 131 166 144 143
Accounts Receivable		 5.21 12 9.11 43 28 37 53
Inventories, net		 1.25 4.82 7.62 8.52 9.81 14 11
Prepaid Expenses		 23 20 18 24 17 26 29
Plant, Property, & Equipment, net		 1.29 1.10 1.06 1.12 1.02 1.02 1.03
Total Noncurrent Assets		 24 49 48 47 83 79 83
Other Noncurrent Operating Assets		 24 49 48 47 83 79 83
Total Liabilities & Shareholders' Equity		 145 217 211 289 342 343 368
Total Liabilities		 78 92 88 98 191 196 210
Total Current Liabilities		 52 63 62 44 57 62 70
Accounts Payable		 3.11 11 5.29 7.74 17 11 16
Accrued Expenses		 7.34 11 12 19 22 27 33
Current Deferred Revenue		 4.00 5.55 5.96 4.07 6.59 11 7.27
Current Employee Benefit Liabilities		 7.17 5.07 6.88 8.36 6.73 10 12
Other Current Liabilities		 3.79 4.00 4.11 4.32 4.31 3.55 2.57
Total Noncurrent Liabilities		 26 29 26 55 135 134 139
Long-Term Debt		 - - - 27 100 100 101
Noncurrent Deferred Revenue		 8.56 11 9.24 10 12 9.61 13
Other Noncurrent Operating Liabilities		 17 17 17 17 23 24 26
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 67 125 123 191 151 147 158
Total Preferred & Common Equity		 67 125 123 191 151 147 158
Total Common Equity		 67 125 123 191 151 147 158
Common Stock		 858 932 947 1,009 1,024 1,036 1,048
Retained Earnings		 -791 -807 -824 -817 -873 -889 -890
Accumulated Other Comprehensive Income / (Loss)		 -0.11 -0.02 -0.21 -0.20 -0.02 -0.10 0.19

Annual Metrics and Ratios for Ardelyx

This table displays calculated financial ratios and metrics derived from Ardelyx's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 9.32% -24.02% -100.00% 0.00% -93.79% 102.57% 43.36% 33.36% 416.57% 138.61% 168.06%
EBITDA Growth		 51.21% -896.94% -290.08% 45.82% -43.02% 0.09% -0.71% -74.56% 60.80% 13.36% 81.79%
EBIT Growth		 51.00% -842.17% -279.05% 43.80% -38.95% -1.31% -0.34% -72.24% 59.57% 8.82% 66.85%
NOPAT Growth		 45.41% -1,779.09% -284.14% 42.32% -39.67% -0.35% 0.53% -70.02% 58.69% 0.76% 55.83%
Net Income Growth		 51.04% -821.62% -279.42% 42.75% -41.90% -3.99% 0.66% -67.70% 57.51% 1.70% 40.76%
EPS Growth		 94.67% -316.13% -117.05% 51.43% -19.12% 9.26% 28.57% -44.76% 72.37% 28.57% 43.33%
Operating Cash Flow Growth		 639.76% -636.24% -28.81% 29.55% -7.80% -8.84% -6.47% -87.33% 54.08% -28.09% 50.06%
Free Cash Flow Firm Growth		 -69.75% -782.12% -0.70% 15.77% 4.69% 0.57% -12.90% -88.12% 59.66% -58.72% 18.85%
Invested Capital Growth		 -31.62% 103.85% -526.93% 169.55% -146.57% -336.34% -7.89% 84.54% 162.56% 2,759.33% 128.96%
Revenue Q/Q Growth		 0.00% -20.87% 0.00% 0.00% -94.15% 70.14% -5.29% -7.17% 478.95% -7.31% 32.47%
EBITDA Q/Q Growth		 0.00% -79.22% -15.10% 41.68% -79.61% 9.29% -12.48% -5.52% 44.97% -281.40% 79.98%
EBIT Q/Q Growth		 0.00% -79.11% -14.55% 40.26% -75.38% 8.29% -11.45% -5.27% 43.47% -206.79% 65.85%
NOPAT Q/Q Growth		 0.00% -78.71% -14.85% 39.46% -72.87% 8.55% -10.73% -5.20% 42.65% -173.37% 56.37%
Net Income Q/Q Growth		 0.00% -78.54% -14.55% 39.15% -71.22% 7.84% -10.66% -4.88% 41.12% -148.65% 46.08%
EPS Q/Q Growth		 0.00% -187.16% 6.67% 37.90% -68.75% 10.91% -5.00% 0.65% 50.59% -400.00% 43.33%
Operating Cash Flow Q/Q Growth		 -52.32% -32.97% -5.89% 32.54% -49.08% 8.71% -8.61% -16.74% 43.42% -34.48% 29.25%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% -5.98% 26.61% -28.26% 9.29% -2.33% -24.58% 46.76% -13.14% -1.88%
Invested Capital Q/Q Growth		 0.00% 144.73% -6.66% 301.28% -161.18% -136.64% -1,556.94% 79.32% -59.30% -39.34% 7.93%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 0.00% 80.00% 82.13% 88.64% 98.08% 90.10% 92.11% 85.70% 84.85%
EBITDA Margin		 -9.00% -118.05% 0.00% -142.72% -3,288.42% -1,621.87% -1,139.32% -1,491.23% -113.16% -41.09% -2.79%
Operating Margin		 -4.95% -122.32% 0.00% -155.04% -3,488.57% -1,728.14% -1,199.05% -1,528.63% -122.24% -50.84% -8.38%
EBIT Margin		 -9.95% -123.41% 0.00% -150.38% -3,366.32% -1,683.60% -1,178.34% -1,521.83% -119.11% -45.51% -5.63%
Profit (Net Income) Margin		 -10.16% -123.29% 0.00% -153.19% -3,502.03% -1,797.77% -1,245.71% -1,566.46% -128.85% -53.08% -11.73%
Tax Burden Percent		 102.13% 99.90% 100.00% 101.87% 100.00% 100.32% 100.00% 100.00% 100.01% 100.83% 100.68%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 104.03% 106.44% 105.72% 102.93% 108.17% 115.67% 207.02%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% -4,466.00% 0.00% 0.00% 0.00% 0.00% -264.67% -36.78%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% -4,444.10% 0.00% 0.00% 0.00% 0.00% -245.88% -20.04%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 4,394.43% 0.00% 0.00% 0.00% 0.00% 214.84% 13.77%
Return on Equity (ROE)		 -12.05% -34.93% -74.42% -38.70% -71.57% -62.78% -60.31% -151.55% -74.28% -49.83% -23.01%
Cash Return on Invested Capital (CROIC)		 0.00% -3,843.81% 0.00% -1,097.99% 0.00% 0.00% 0.00% 0.00% -4,206.04% -451.16% -115.19%
Operating Return on Assets (OROA)		 -4.03% -25.74% 0.00% -34.05% -51.44% -40.13% -38.67% -87.44% -36.55% -23.23% -5.12%
Return on Assets (ROA)		 -4.11% -25.72% 0.00% -34.68% -53.51% -42.85% -40.89% -90.00% -39.54% -27.10% -10.67%
Return on Common Equity (ROCE)		 0.63% -34.93% -74.42% -38.70% -71.57% -62.78% -60.31% -151.55% -74.28% -49.83% -23.01%
Return on Equity Simple (ROE_SIMPLE)		 -5.30% -27.20% -58.19% -46.18% -78.83% -50.86% -74.79% -191.44% -68.35% -39.60% -22.58%
Net Operating Profit after Tax (NOPAT)		 -1.09 -21 -79 -46 -64 -64 -64 -108 -45 -44 -20
NOPAT Margin		 -3.46% -85.63% 0.00% -108.53% -2,442.00% -1,209.70% -839.33% -1,070.04% -85.57% -35.59% -5.86%
Net Nonoperating Expense Percent (NNEP)		 -3.13% -8.44% -21.67% -11.21% -21.91% -19.67% -18.35% -45.11% -24.86% -18.80% -16.75%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -35.69% -20.45% -6.04%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 20.00% 17.88% 11.36% 1.92% 9.90% 7.89% 14.30% 15.15%
SG&A Expenses to Revenue		 23.04% 56.31% 0.00% 55.31% 909.67% 459.52% 437.89% 716.08% 146.86% 107.99% 77.54%
R&D to Revenue		 81.90% 166.01% 0.00% 179.72% 2,661.03% 1,357.26% 859.24% 902.64% 67.49% 28.55% 15.68%
Operating Expenses to Revenue		 104.95% 22.32% 0.00% 235.04% 3,570.69% 1,816.78% 1,297.13% 1,618.73% 214.35% 136.54% 93.22%
Earnings before Interest and Taxes (EBIT)		 -3.15 -30 -112 -63 -88 -89 -89 -154 -62 -57 -19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.85 -28 -111 -60 -86 -86 -86 -151 -59 -51 -9.31
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.77 4.32 3.48 2.25 0.96 2.53 4.63 1.50 5.43 8.63 6.93
Price to Tangible Book Value (P/TBV)		 5.77 4.32 3.48 2.25 0.96 2.53 4.63 1.50 5.43 8.63 6.93
Price to Revenue (P/Rev)		 11.07 19.58 0.00 7.47 42.66 89.40 77.12 12.28 10.24 11.56 3.60
Price to Earnings (P/E)		 0.00 25.52 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 3.92% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 202.19 0.00 33.69 0.00 0.00 0.00 0.00 386.44 40.35 14.88
Enterprise Value to Revenue (EV/Rev)		 7.68 15.12 0.00 4.28 0.00 52.00 58.92 3.92 8.38 10.48 3.30
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 23.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.43 0.27 0.40 0.39 0.27 0.30 0.87
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.43 0.26 0.37 0.00 0.00 0.30 0.87
Financial Leverage		 -2.54 -1.26 -1.02 -1.01 -0.99 -1.04 -1.07 -1.06 -1.00 -0.87 -0.69
Leverage Ratio		 2.93 1.36 1.09 1.12 1.34 1.47 1.48 1.68 1.88 1.84 2.16
Compound Leverage Factor		 2.93 1.36 1.09 1.12 1.39 1.56 1.56 1.73 2.03 2.13 4.46
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 30.07% 21.13% 28.71% 28.08% 21.36% 23.00% 46.54%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.50% 2.36% 28.08% 21.36% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 30.07% 20.63% 26.35% 0.00% 0.00% 23.00% 46.54%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 69.93% 78.87% 71.29% 71.92% 78.64% 77.00% 53.46%
Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.58 -0.58 -0.59 -0.21 -0.45 -0.97 -16.20
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 1.38 2.31 1.60 0.56 1.65 2.63 10.66
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.58 -0.57 -0.54 0.00 0.00 -0.97 -16.20
Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.78 -0.78 -0.80 -0.30 -0.60 -1.12 -7.71
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 1.86 3.09 2.17 0.78 2.18 3.04 5.07
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.78 -0.76 -0.73 0.00 0.00 -1.12 -7.71
Altman Z-Score		 4.23 34.30 18.07 7.61 -2.33 1.34 0.36 -8.22 -2.50 3.20 1.29
Noncontrolling Interest Sharing Ratio		 105.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.16 14.51 10.62 8.38 9.95 11.34 6.85 2.53 2.34 4.88 4.58
Quick Ratio		 5.10 13.86 10.46 8.10 9.49 11.14 6.56 2.22 2.01 4.09 3.95
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 10 -69 -70 -59 -56 -56 -63 -118 -48 -76 -61
Operating Cash Flow to CapEx		 721.82% -2,079.91% -1,901.64% -2,768.15% -22,596.14% -23,533.54% -25,134.26% -8,170.92% 0.00% -26,080.52% -4,432.15%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 -15.80 -9.70 -12.29 -26.20 -9.38 -8.51 -3.05
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 -19.89 -13.36 -15.97 -33.89 -13.81 -10.11 -2.23
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 -19.97 -13.41 -16.03 -34.30 -13.46 -10.15 -2.28
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.40 0.21 0.00 0.23 0.02 0.02 0.03 0.06 0.31 0.51 0.91
Accounts Receivable Turnover		 7.01 0.00 0.00 0.00 0.48 0.00 0.00 0.00 12.67 8.36 8.37
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.26 3.01
Fixed Asset Turnover		 23.77 7.02 0.00 4.93 0.38 1.17 2.82 4.70 29.10 111.52 266.47
Accounts Payable Turnover		 0.00 0.00 0.00 1.76 0.18 0.36 0.04 0.20 0.54 1.62 3.73
Days Sales Outstanding (DSO)		 52.06 0.00 0.00 0.00 761.71 0.00 0.00 0.00 28.81 43.65 43.62
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 161.32 121.37
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 207.88 1,989.88 1,014.40 9,833.60 1,807.30 670.95 225.59 97.96
Cash Conversion Cycle (CCC)		 52.06 0.00 0.00 -207.88 -1,228.16 -1,014.40 -9,833.60 -1,807.30 -642.14 -20.63 67.02
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -47 1.80 -7.67 5.34 -2.49 -11 -12 -1.81 1.13 32 74
Invested Capital Turnover		 -0.77 -1.07 0.00 -35.96 1.83 -0.79 -0.67 -1.50 -154.09 7.44 6.27
Increase / (Decrease) in Invested Capital		 -11 49 -9.47 13 -7.82 -8.36 -0.86 9.89 2.94 31 42
Enterprise Value (EV)		 243 363 471 180 -7.08 275 446 40 437 1,305 1,102
Market Capitalization		 350 470 672 314 111 472 584 124 534 1,439 1,201
Book Value per Share		 $3.27 $4.20 $4.08 $2.93 $1.86 $2.97 $1.40 $0.73 $0.52 $0.72 $0.73
Tangible Book Value per Share		 $3.27 $4.20 $4.08 $2.93 $1.86 $2.97 $1.40 $0.73 $0.52 $0.72 $0.73
Total Capital		 61 109 193 139 166 237 177 115 125 217 324
Total Debt		 0.00 0.00 0.00 0.00 50 50 51 32 27 50 151
Total Long-Term Debt		 0.00 0.00 0.00 0.00 50 49 47 0.00 0.00 50 151
Net Debt		 -107 -107 -201 -134 -118 -197 -138 -84 -97 -134 -99
Capital Expenditures (CapEx)		 1.86 3.45 4.87 2.36 0.31 0.33 0.32 1.87 -1.74 0.34 1.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -18 -2.70 -16 -2.14 -9.45 -16 -16 -3.60 -9.20 11 29
Debt-free Net Working Capital (DFNWC)		 90 104 185 132 159 231 170 113 115 196 279
Net Working Capital (NWC)		 90 104 185 132 159 230 166 81 88 196 279
Net Nonoperating Expense (NNE)		 2.12 9.05 33 19 28 31 31 50 23 22 20
Net Nonoperating Obligations (NNO)		 -107 -107 -201 -134 -118 -197 -138 -84 -97 -134 -99
Total Depreciation and Amortization (D&A)		 0.30 1.29 1.75 3.22 2.03 3.26 2.95 3.09 3.11 5.51 9.46
Debt-free, Cash-free Net Working Capital to Revenue		 -56.11% -11.22% 0.00% -5.08% -362.33% -312.19% -211.95% -35.62% -17.63% 9.18% 8.55%
Debt-free Net Working Capital to Revenue		 283.16% 434.15% 0.00% 313.91% 6,085.27% 4,374.65% 2,251.18% 1,120.06% 219.93% 157.26% 83.52%
Net Working Capital to Revenue		 283.16% 434.15% 0.00% 313.91% 6,085.27% 4,352.24% 2,196.14% 800.52% 168.72% 157.26% 83.52%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.31) ($1.29) ($2.80) ($1.36) ($1.62) ($1.47) ($1.05) ($1.52) ($0.42) ($0.30) ($0.17)
Adjusted Weighted Average Basic Shares Outstanding		 18.60M 34.63M 47.33M 47.60M 62.60M 88.93M 98.68M 104.21M 158.69M 219.33M 235.23M
Adjusted Diluted Earnings per Share		 ($0.31) ($1.29) ($2.80) ($1.36) ($1.62) ($1.47) ($1.05) ($1.52) ($0.42) ($0.30) ($0.17)
Adjusted Weighted Average Diluted Shares Outstanding		 18.60M 34.63M 47.33M 47.60M 62.60M 88.93M 98.68M 104.21M 158.69M 219.33M 235.23M
Adjusted Basic & Diluted Earnings per Share		 ($0.31) ($1.29) ($2.80) ($1.36) ($1.62) ($1.47) ($1.05) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 10.25M 22.89M 40.12M 47.44M 56.22M 64.48M 89.58M 130.29M 206.49M 232.69M 238.36M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.09 -21 -79 -46 -64 -64 -64 -108 -45 -44 -20
Normalized NOPAT Margin		 -3.46% -85.63% 0.00% -108.53% -2,442.00% -1,209.70% -839.33% -1,070.04% -85.57% -35.59% -5.86%
Pre Tax Income Margin		 -9.95% -123.41% 0.00% -150.38% -3,501.88% -1,792.03% -1,245.69% -1,566.42% -128.84% -52.65% -11.65%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 -24.83 -15.53 -17.50 -34.13 -12.25 -6.38 -0.93
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 -18.01 -11.16 -12.46 -24.00 -8.80 -4.99 -0.97
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 -24.92 -15.58 -17.56 -34.55 -11.90 -6.42 -0.98
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 -18.10 -11.21 -12.53 -24.41 -8.45 -5.03 -1.02
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Ardelyx

This table displays calculated financial ratios and metrics derived from Ardelyx's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 325.06% 4,193.29% 2,329.27% 784.13% 1,030.99% -22.22% 304.81% 227.86% 74.21% 237.95%
EBITDA Growth		 51.83% 139.07% 11.33% 55.21% 141.67% -278.39% 15.05% 19.98% -15.16% 153.89%
EBIT Growth		 50.02% 135.51% 9.37% 42.33% 141.83% -305.02% 9.79% 23.83% -49.03% 141.04%
NOPAT Growth		 48.20% 149.18% 6.27% 36.59% 146.89% -261.33% 5.32% 18.01% -78.23% 141.16%
Net Income Growth		 47.48% 129.52% 4.62% 36.44% 128.96% -369.30% 0.95% 3.90% -112.20% 116.13%
EPS Growth		 66.67% 138.71% 38.10% 57.89% 121.43% -200.00% 15.38% 12.50% -100.00% 108.33%
Operating Cash Flow Growth		 26.49% 136.19% -62.18% 52.89% 15.57% -161.03% 20.25% -31.63% 102.33% 212.53%
Free Cash Flow Firm Growth		 -24.66% 126.62% -140.03% -81.61% -61.52% -651.91% -9.98% -34.34% 68.33% 33.78%
Invested Capital Growth		 131.79% 162.56% 3,408.48% 1,517.28% 1,818.32% 2,759.33% 119.57% 170.73% 28.69% 128.96%
Revenue Q/Q Growth		 97.39% 786.04% -74.27% 96.44% 152.50% -39.06% 33.93% 59.10% 34.17% 18.21%
EBITDA Q/Q Growth		 22.59% 167.78% -275.04% 51.23% 172.01% -390.18% 16.65% 54.06% 176.34% 84.32%
EBIT Q/Q Growth		 19.01% 159.11% -297.81% 39.11% 158.75% -389.73% 12.96% 48.59% 139.31% 133.29%
NOPAT Q/Q Growth		 16.54% 179.28% -250.25% 36.22% 161.71% -372.79% 11.82% 44.77% 116.38% 415.91%
Net Income Q/Q Growth		 15.02% 146.72% -350.33% 36.05% 138.72% -534.48% 7.93% 37.95% 95.08% 674.17%
EPS Q/Q Growth		 26.32% 185.71% -208.33% 38.46% 137.50% -500.00% 8.33% 36.36% 100.00% 0.00%
Operating Cash Flow Q/Q Growth		 18.71% 156.18% -413.60% 67.10% -45.67% 59.39% -309.75% 45.70% 102.58% 1,858.08%
Free Cash Flow Firm Q/Q Growth		 -35.89% 134.29% -529.68% 9.31% -20.86% -17.18% 14.38% -10.79% 71.51% -145.02%
Invested Capital Q/Q Growth		 274.01% -59.30% 1,838.82% 3.22% 135.53% -39.34% 48.88% 27.27% 11.95% 7.93%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 85.32% 92.84% 86.48% 84.38% 86.36% 85.23% 84.51% 87.11% 83.99% 84.27%
EBITDA Margin		 -400.98% 30.68% -208.65% -51.80% 14.77% -70.35% -43.78% -12.64% 7.19% 11.22%
Operating Margin		 -438.83% 27.49% -229.26% -74.44% 13.12% -81.44% -53.62% -18.61% 2.27% 7.00%
EBIT Margin		 -424.71% 28.34% -217.80% -67.51% 15.71% -74.69% -48.54% -15.69% 4.60% 9.07%
Profit (Net Income) Margin		 -459.15% 24.21% -235.49% -76.66% 11.76% -83.82% -57.62% -22.47% -0.82% 4.00%
Tax Burden Percent		 100.00% 100.00% 100.05% 100.00% 97.07% 101.17% 100.46% 100.41% 105.61% 99.25%
Interest Burden Percent		 108.11% 85.44% 108.06% 113.55% 77.09% 110.93% 118.17% 142.68% -16.97% 44.43%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 2.93% 0.00% 0.00% 0.00% 0.00% 0.75%
Return on Invested Capital (ROIC)		 0.00% 0.00% -897.41% -410.50% 60.97% -423.97% -170.45% -65.22% 6.57% 43.55%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% -887.20% -403.43% 61.52% -416.02% -161.49% -57.80% 8.66% 46.48%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 781.67% 355.26% -48.15% 363.51% 120.53% 39.84% -5.64% -31.94%
Return on Equity (ROE)		 -153.93% -74.28% -115.74% -55.23% 12.83% -60.47% -49.92% -25.38% 0.94% 11.61%
Cash Return on Invested Capital (CROIC)		 -3,214.99% -4,206.04% -573.89% -269.19% -237.96% -451.16% -198.48% -190.37% -98.65% -115.19%
Operating Return on Assets (OROA)		 -24.25% 8.69% -79.29% -32.64% 9.72% -38.12% -27.61% -11.88% 3.52% 8.25%
Return on Assets (ROA)		 -26.22% 7.43% -85.73% -37.06% 7.27% -42.78% -32.78% -17.01% -0.63% 3.64%
Return on Common Equity (ROCE)		 -153.93% -74.28% -115.74% -55.23% 12.83% -60.47% -49.92% -25.38% 0.94% 11.61%
Return on Equity Simple (ROE_SIMPLE)		 -170.71% 0.00% -52.55% -45.54% -13.90% 0.00% -43.62% -44.32% -45.85% 0.00%
Net Operating Profit after Tax (NOPAT)		 -15 12 -18 -12 7.18 -20 -17 -9.54 1.56 8.06
NOPAT Margin		 -307.18% 27.49% -160.48% -52.11% 12.73% -57.01% -37.53% -13.03% 1.59% 6.94%
Net Nonoperating Expense Percent (NNEP)		 -9.82% -1.59% -10.21% -7.07% -0.55% -7.95% -8.96% -7.42% -2.08% -2.93%
Return On Investment Capital (ROIC_SIMPLE)		 - 9.71% - - - -9.04% - - - 2.49%
Cost of Revenue to Revenue		 14.68% 7.16% 13.52% 15.62% 13.64% 14.77% 15.49% 12.89% 16.01% 15.73%
SG&A Expenses to Revenue		 374.39% 44.66% 235.76% 121.73% 57.92% 138.95% 115.15% 88.30% 66.13% 65.51%
R&D to Revenue		 149.76% 20.69% 79.98% 37.08% 15.32% 27.72% 22.99% 17.43% 15.58% 11.77%
Operating Expenses to Revenue		 524.15% 65.36% 315.74% 158.81% 73.24% 166.67% 138.13% 105.73% 81.72% 77.28%
Earnings before Interest and Taxes (EBIT)		 -21 13 -25 -15 8.86 -26 -22 -11 4.52 11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -20 14 -24 -12 8.33 -24 -20 -9.26 7.07 13
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 2.75 5.43 7.89 5.90 4.65 8.63 11.23 11.80 10.25 6.93
Price to Tangible Book Value (P/TBV)		 2.75 5.43 7.89 5.90 4.65 8.63 11.23 11.80 10.25 6.93
Price to Revenue (P/Rev)		 20.43 10.24 15.69 8.77 6.62 11.56 10.65 8.26 6.44 3.60
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 43.16 386.44 40.39 27.68 14.09 40.35 33.06 26.89 22.34 14.88
Enterprise Value to Revenue (EV/Rev)		 13.31 8.38 14.04 7.56 5.59 10.48 10.00 7.85 6.08 3.30
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.40 0.27 0.21 0.22 0.14 0.30 0.66 0.68 0.64 0.87
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.14 0.30 0.66 0.68 0.64 0.87
Financial Leverage		 -1.04 -1.00 -0.88 -0.88 -0.78 -0.87 -0.75 -0.69 -0.65 -0.69
Leverage Ratio		 2.13 1.88 1.83 1.95 1.68 1.84 2.02 2.05 1.88 2.16
Compound Leverage Factor		 2.30 1.61 1.97 2.21 1.30 2.04 2.39 2.93 -0.32 0.96
Debt to Total Capital		 28.42% 21.36% 17.65% 18.01% 12.47% 23.00% 39.82% 40.55% 38.88% 46.54%
Short-Term Debt to Total Capital		 28.42% 21.36% 17.65% 18.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 12.47% 23.00% 39.82% 40.55% 38.88% 46.54%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 71.58% 78.64% 82.35% 81.99% 87.53% 77.00% 60.18% 59.45% 61.12% 53.46%
Debt to EBITDA		 -0.25 -0.45 -0.48 -0.65 -2.03 -0.97 -2.10 -2.22 -2.17 -16.20
Net Debt to EBITDA		 0.60 1.65 1.85 2.41 10.28 2.63 2.16 1.89 1.93 10.66
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 -2.03 -0.97 -2.10 -2.22 -2.17 -16.20
Debt to NOPAT		 -0.34 -0.60 -0.62 -0.74 -1.68 -1.12 -2.30 -2.43 -2.25 -7.71
Net Debt to NOPAT		 0.82 2.18 2.38 2.74 8.51 3.04 2.37 2.08 2.00 5.07
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 -1.68 -1.12 -2.30 -2.43 -2.25 -7.71
Altman Z-Score		 -6.09 -1.20 1.76 0.22 2.86 3.55 2.70 2.87 2.68 1.51
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 2.31 2.34 2.65 2.63 5.54 4.88 4.53 4.21 4.03 4.58
Quick Ratio		 1.84 2.01 2.26 2.22 4.79 4.09 4.06 3.57 3.46 3.95
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -27 9.20 -40 -36 -43 -51 -43 -48 -14 -34
Operating Cash Flow to CapEx		 0.00% 25,970.91% -319,964.29% -15,846.24% -11,065.46% -20,274.42% -23,814.67% -14,807.63% 365.69% 1,654.30%
Free Cash Flow to Firm to Interest Expense		 -15.63 5.02 -19.80 -17.56 -21.37 -18.11 -10.72 -9.83 -2.60 -5.75
Operating Cash Flow to Interest Expense		 -14.81 7.79 -22.43 -7.21 -10.58 -3.11 -8.80 -3.96 0.09 1.68
Operating Cash Flow Less CapEx to Interest Expense		 -14.50 7.76 -22.44 -7.26 -10.68 -3.12 -8.84 -3.98 0.07 1.57
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.06 0.31 0.36 0.48 0.62 0.51 0.57 0.76 0.77 0.91
Accounts Receivable Turnover		 3.28 12.67 7.64 11.25 5.54 8.36 7.90 9.06 5.22 8.37
Inventory Turnover		 0.00 0.00 1.34 1.47 3.25 2.26 3.20 2.74 3.76 3.01
Fixed Asset Turnover		 4.57 29.10 40.08 63.62 111.43 111.52 150.03 201.92 234.93 266.47
Accounts Payable Turnover		 0.26 0.54 0.72 1.86 2.93 1.62 1.68 3.63 3.17 3.73
Days Sales Outstanding (DSO)		 111.32 28.81 47.79 32.45 65.88 43.65 46.20 40.28 69.90 43.62
Days Inventory Outstanding (DIO)		 0.00 0.00 272.32 248.50 112.33 161.32 114.22 132.98 97.20 121.37
Days Payable Outstanding (DPO)		 1,409.55 670.95 509.35 196.17 124.68 225.59 216.87 100.64 115.06 97.96
Cash Conversion Cycle (CCC)		 -1,298.23 -642.14 -189.24 84.78 53.53 -20.63 -56.45 72.62 52.03 67.02
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 2.78 1.13 22 23 53 32 48 61 69 74
Invested Capital Turnover		 -3.02 -154.09 5.59 7.88 4.79 7.44 4.54 5.01 4.13 6.27
Increase / (Decrease) in Invested Capital		 12 2.94 21 24 51 31 26 39 15 42
Enterprise Value (EV)		 120 437 886 627 751 1,305 1,592 1,648 1,532 1,102
Market Capitalization		 184 534 989 727 889 1,439 1,695 1,734 1,622 1,201
Book Value per Share		 $0.43 $0.52 $0.61 $0.57 $0.88 $0.72 $0.65 $0.63 $0.67 $0.73
Tangible Book Value per Share		 $0.43 $0.52 $0.61 $0.57 $0.88 $0.72 $0.65 $0.63 $0.67 $0.73
Total Capital		 93 125 152 150 218 217 251 247 259 324
Total Debt		 27 27 27 27 27 50 100 100 101 151
Total Long-Term Debt		 0.00 0.00 0.00 0.00 27 50 100 100 101 151
Net Debt		 -64 -97 -103 -101 -138 -134 -103 -86 -90 -99
Capital Expenditures (CapEx)		 -0.53 0.06 0.01 0.09 0.19 0.04 0.15 0.13 0.14 0.59
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 3.84 -9.20 0.49 -0.10 33 11 -1.53 15 23 29
Debt-free Net Working Capital (DFNWC)		 94 115 131 127 198 196 201 201 214 279
Net Working Capital (NWC)		 68 88 104 100 198 196 201 201 214 279
Net Nonoperating Expense (NNE)		 7.58 1.45 8.53 5.48 0.55 9.21 9.24 6.91 2.37 3.42
Net Nonoperating Obligations (NNO)		 -64 -97 -103 -101 -138 -134 -103 -86 -90 -99
Total Depreciation and Amortization (D&A)		 1.18 1.03 1.04 3.51 -0.53 1.49 2.19 2.23 2.55 2.50
Debt-free, Cash-free Net Working Capital to Revenue		 42.65% -17.63% 0.78% -0.12% 24.28% 9.18% -0.96% 6.96% 9.21% 8.55%
Debt-free Net Working Capital to Revenue		 1,048.56% 219.93% 207.53% 153.84% 147.23% 157.26% 126.36% 95.52% 84.81% 83.52%
Net Working Capital to Revenue		 753.96% 168.72% 164.90% 121.19% 147.23% 157.26% 126.36% 95.52% 84.81% 83.52%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.14) $0.12 ($0.13) ($0.08) $0.03 ($0.12) ($0.11) ($0.07) $0.00 $0.01
Adjusted Weighted Average Basic Shares Outstanding		 165.10M 158.69M 207.02M 214.95M 222.78M 219.33M 233.07M 234.57M 235.91M 235.23M
Adjusted Diluted Earnings per Share		 ($0.14) $0.12 ($0.13) ($0.08) $0.03 ($0.12) ($0.11) ($0.07) $0.00 $0.01
Adjusted Weighted Average Diluted Shares Outstanding		 165.10M 158.69M 207.02M 214.95M 227.89M 219.33M 233.07M 234.57M 235.91M 235.23M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 187.46M 206.49M 214.46M 217.86M 232.14M 232.69M 233.98M 235.43M 236.85M 238.36M
Normalized Net Operating Profit after Tax (NOPAT)		 -15 8.50 -18 -12 7.18 -20 -17 -9.54 1.56 8.06
Normalized NOPAT Margin		 -307.18% 19.24% -160.48% -52.11% 12.73% -57.01% -37.53% -13.03% 1.59% 6.94%
Pre Tax Income Margin		 -459.15% 24.21% -235.37% -76.66% 12.11% -82.85% -57.36% -22.38% -0.78% 4.03%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -12.33 6.83 -12.40 -7.38 4.37 -9.15 -5.50 -2.34 0.86 1.80
NOPAT to Interest Expense		 -8.92 6.62 -9.14 -5.70 3.54 -6.98 -4.26 -1.95 0.30 1.38
EBIT Less CapEx to Interest Expense		 -12.02 6.80 -12.41 -7.43 4.27 -9.16 -5.54 -2.37 0.83 1.70
NOPAT Less CapEx to Interest Expense		 -8.61 6.59 -9.14 -5.74 3.44 -7.00 -4.29 -1.97 0.27 1.28
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Ardelyx's Financials

When does Ardelyx's financial year end?

According to the most recent income statement we have on file, Ardelyx's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Ardelyx's net income changed over the last 10 years?

Ardelyx's net income appears to be on an upward trend, with a most recent value of -$39.14 million in 2024, rising from -$3.21 million in 2014. The previous period was -$66.07 million in 2023.

What is Ardelyx's operating income?
Ardelyx's total operating income in 2024 was -$27.95 million, based on the following breakdown:
  • Total Gross Profit: $283.06 million
  • Total Operating Expenses: $311.01 million
How has Ardelyx revenue changed over the last 10 years?

Over the last 10 years, Ardelyx's total revenue changed from $31.62 million in 2014 to $333.62 million in 2024, a change of 955.0%.

How much debt does Ardelyx have?

Ardelyx's total liabilities were at $262.47 million at the end of 2024, a 100.7% increase from 2023, and a 397.7% increase since 2014.

How much cash does Ardelyx have?

In the past 10 years, Ardelyx's cash and equivalents has ranged from $21.47 million in 2023 to $181.13 million in 2019, and is currently $64.93 million as of their latest financial filing in 2024.

How has Ardelyx's book value per share changed over the last 10 years?

Over the last 10 years, Ardelyx's book value per share changed from 3.27 in 2014 to 0.73 in 2024, a change of -77.6%.


Related Companies

This page (NASDAQ:ARDX) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
How War with China Could Start in 128 Days
The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...
Behind the Markets | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
🥾⛏️👷‍♂️ What I Learned From Numerous Mine Visits...
Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...
Golden Portfolio | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...
Paradigm Press | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored